TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10741192

Group type: EXPERIMENTAL
Intervention: Sufentanil 10 micrograms + Bupivacaine 2.5 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fentanyl 10 micrograms + Bupivacaine 2.5 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Plain Bupivacaine 2.5 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (1 mL saline) + Bupivacaine 2.5 mg
Number of subjects: 60
Study: 7746058

Group type: EXPERIMENTAL
Intervention: Simvastatin therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2257859

Group type: EXPERIMENTAL
Intervention: Controlled-release theophylline 650 mg once daily in the evening
Number of subjects: 36

Group type: COMPARATOR
Intervention: Controlled-release terbutaline 7.5 mg b.d.
Number of subjects: 36
Study: 396305

Group type: EXPERIMENTAL
Intervention: Sorbitol and sucrose flavored gum
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Xylitol and sucrose flavored gum
Number of subjects: 27

Group type: COMPARATOR
Intervention: No oral hygiene control group
Number of subjects: 27
Study: 29279188

Group type: EXPERIMENTAL
Intervention: 30-day seizure frequency
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 6-month seizure frequency
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Total NHE count
Number of subjects: 120
Study: 27604086

Group type: EXPERIMENTAL
Intervention: Calanus Oil (4g providing 260mg EPA and 156mg DHA)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Lovaza (1 capsule providing 465mg EPA and 375mg DHA)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Calanus Oil and Lovaza (comparison)
Number of subjects: 18
Study: 25781221

Group type: EXPERIMENTAL
Intervention: Nutrient-rich diet (green vegetables, beef, whole milk, full-fat butter) for three months
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Green vegetables according to diet guidelines
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Whole milk consumed almost daily
Number of subjects: 98
Study: 23791061

Group type: EXPERIMENTAL
Intervention: Cold autologous blood cardioplegic solution
Number of subjects: 96

Group type: COMPARATOR
Intervention: HTK solution
Number of subjects: 96

Group type: COMPARATOR
Intervention: Cold non-autologous blood cardioplegic solution
Number of subjects: 96
Study: 19879118

Group type: EXPERIMENTAL
Intervention: Pure mastic gum 350mg tid for 14 days (Group A)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Pure mastic gum 1.05g tid for 14 days (Group B)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Pantoprazole 20mg bd plus pure mastic gum 350mg tid for 14 days (Group C)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Pantoprazole 20mg bd plus amoxicillin 1g bd plus clarithromycin 500mg bd for 10 days (Group D)
Number of subjects: 52
Study: 17991875

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 2926

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2926
Study: 16780616

Group type: EXPERIMENTAL
Intervention: Acetylcysteine 1200 mg the day before and 600 mg at the operative day
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Ischaemic preconditioning
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 31
Study: 11153971

Group type: EXPERIMENTAL
Intervention: One-session exposure (E1)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Five-sessions exposure (E5)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Five-sessions cognitive therapy (C5)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 46
Study: 9842028

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no spinal cord stimulation)
Number of subjects: 25
Study: 8186063

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (100 mg at 16.00 h)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Desipramine (DMI) (100 mg at 16.00 h)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Desipramine (DMI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 0
Study: 2687687

Group type: EXPERIMENTAL
Intervention: Rimantadine (200 mg per day for 10 days)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 237
Study: 8172091

Group type: EXPERIMENTAL
Intervention: 54 g psyllium-enriched cereal/d containing 7.3 g psyllium
Number of subjects: 18

Group type: COMPARATOR
Intervention: 7.6 g of psyllium taken between meals
Number of subjects: 18
Study: 215338

Group type: EXPERIMENTAL
Intervention: Colestipol (30 g/day) and diet
Number of subjects: 25
Study: 30910061

Group type: EXPERIMENTAL
Intervention: Intranasal ketamine
Number of subjects: 53

Group type: COMPARATOR
Intervention: Intravenous metoclopramide and diphenhydramine (control)
Number of subjects: 53
Study: 28745354

Group type: EXPERIMENTAL
Intervention: Isoflavone therapy (80 mg day-1)
Number of subjects: 200
Study: 26342471

Group type: EXPERIMENTAL
Intervention: Absorb bioresorbable vascular scaffold (Absorb BVS)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Durable polymer everolimus-eluting metallic stent (EES)
Number of subjects: 191
Study: 24345171

Group type: EXPERIMENTAL
Intervention: Standard Stroop color identification task (50% congruent/incongruent)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reverse Stroop word identification task (50%/50%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reverse Stroop word identification task (80%/20%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NINC (frontocentral negative polarity incongruency wave)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LPC (late positive component)
Number of subjects: 0
Study: 22514508

Group type: EXPERIMENTAL
Intervention: PICO queries
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard queries
Number of subjects: 22
Study: 19295472

Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 519
Study: 18095506

Group type: EXPERIMENTAL
Intervention: On‐line guidance by multiplane TEE
Number of subjects: 55

Group type: COMPARATOR
Intervention: On‐line guidance by intracardiac echocardiography
Number of subjects: 55
Study: 15354150

Group type: EXPERIMENTAL
Intervention: Calcium-rich diet supplying at least 1,500 mg of calcium per day
Number of subjects: 59

Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 59
Study: 11965512

Group type: EXPERIMENTAL
Intervention: Abacor (isolated soy protein with high levels of isoflavones and cotyledon soy fibres), given as two daily liquid supplements for 6 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo, given as two daily liquid supplements for 6 weeks
Number of subjects: 60
Study: 10681768

Group type: EXPERIMENTAL
Intervention: Injection of 4000U SOD immediately after radiotherapy
Number of subjects: 159
Study: 7716842

Group type: EXPERIMENTAL
Intervention: Goserelin 3.6 mg subcutaneously every 4 weeks and flutamide 250 mg orally three times daily 2 months before and during radiation therapy (Arm I)
Number of subjects: 456

Group type: COMPARATOR
Intervention: Radiation therapy alone (Arm II)
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Goserelin and flutamide (Arm I)
Number of subjects: 456
Study: 2715477

Group type: EXPERIMENTAL
Intervention: Clinical evaluation (history, examination, imaging)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Arthrographic diagnosis
Number of subjects: 60
Study: 4407

Group type: EXPERIMENTAL
Intervention: Clorimipramine
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Doxepine
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Dibenzepine
Number of subjects: 107
Study: 31319828

Group type: EXPERIMENTAL
Intervention: Participatory Learning and Action (PLA) meetings with women's groups and home visits
Number of subjects: 4668

Group type: EXPERIMENTAL
Intervention: Participatory Learning and Action (PLA) meetings, home visits, and crèches
Number of subjects: 4668

Group type: COMPARATOR
Intervention: Control group (Area 1)
Number of subjects: 4668
Study: 28011612

Group type: EXPERIMENTAL
Intervention: 14 days of oral vancomycin followed by a single 500-mL fecal transplantation (FT) by enema
Number of subjects: 30

Group type: COMPARATOR
Intervention: 6-week taper of oral vancomycin
Number of subjects: 30
Study: 25893991

Group type: EXPERIMENTAL
Intervention: Flavonoids mixture (diosmin, troxerutin, hesperidin)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study: 23993864

Group type: EXPERIMENTAL
Intervention: REPYFLEC cognitive remediation (CR)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Leisure activities (control)
Number of subjects: 62
Study: 21370406

Group type: EXPERIMENTAL
Intervention: Primary nephrectomy
Number of subjects: 47

Group type: COMPARATOR
Intervention: Alternative diagnoses consideration
Number of subjects: 47
Study: 19686522

Group type: EXPERIMENTAL
Intervention: Abstinence-contingent employment (n = 27)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Employment-only (control, n = 24)
Number of subjects: 128
Study: 17386321

Group type: EXPERIMENTAL
Intervention: Helixone membrane
Number of subjects: 60

Group type: COMPARATOR
Intervention: High-flux polysulfone membrane (HF80)
Number of subjects: 60
Study: 15305403

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 9366

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 9366

Group type: EXPERIMENTAL
Intervention: Anastrozole plus Tamoxifen
Number of subjects: 9366
Study: 11465583

Group type: EXPERIMENTAL
Intervention: Hypothermic group (no active warming)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normothermic group (active forced-air warming)
Number of subjects: 20
Study: 9928555

Group type: EXPERIMENTAL
Intervention: Complete axillary dissection as part of radical mastectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modified radical mastectomy or breast conservation approach with lumpectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Level I-II dissection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sentinel lymphadenectomy
Number of subjects: 0
Study: 8306269

Group type: EXPERIMENTAL
Intervention: Radioimmunodetection with anti-carcinoembryonic antigen MoAb FO23C5, radiolabelled with 131I
Number of subjects: 59

Group type: COMPARATOR
Intervention: Magnetic resonance imaging
Number of subjects: 59

Group type: COMPARATOR
Intervention: Computed tomography
Number of subjects: 59

Group type: COMPARATOR
Intervention: Ultrasonography
Number of subjects: 59
Study: 3055930

Group type: EXPERIMENTAL
Intervention: 15 mg of beta-carotene daily
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 29776895

Group type: EXPERIMENTAL
Intervention: Immediate islet transplantation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Insulin therapy
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Islet transplantation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Islet transplantation (no prior kidney graft)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Islet transplantation (prior kidney graft)
Number of subjects: 50
Study: 26990084

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 46
Study: 25223504

Group type: EXPERIMENTAL
Intervention: St John's wort with metformin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Metformin alone
Number of subjects: 20
Study: 23953078

Group type: EXPERIMENTAL
Intervention: Newer therapies and devices combined with comprehensive care plans involving adequate patient education
Number of subjects: 0
Study: 21131672

Group type: EXPERIMENTAL
Intervention: Horticultural therapy-based programming (HT-based); implemented twice weekly for 6 weeks at 4 treatment sites.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional activities (TA) programming; regular activities observed at comparison sites.
Number of subjects: 0
Study: 18055486

Group type: EXPERIMENTAL
Intervention: Prasugrel 60 mg loading dose (LD) and 10 mg maintenance dose (MD)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Clopidogrel 600 mg loading dose (LD) and 75 mg maintenance dose (MD)
Number of subjects: 110
Study: 16005674

Group type: COMPARATOR
Intervention: Climène (estradiol valerate 2 mg, from D1 to D21/cyproterone acetate 1 mg, from D12 to D21, followed by 7 days off)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Climodiène (estradiol valerate 2 mg/dienogest 2 mg)
Number of subjects: 143
Study: 12904855

Group type: EXPERIMENTAL
Intervention: Fiberoptic endoscopic evaluation of swallowing (FEES) performed within 48 h post‐extubation and on days 5, 9, and 14 for those with evidence of aspiration.
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (younger cohort <65 years)
Number of subjects: 42
Study: 10596768

Group type: EXPERIMENTAL
Intervention: Zinc and copper salt supplementation
Number of subjects: 2

Group type: COMPARATOR
Intervention: No zinc and copper salt supplementation (Control)
Number of subjects: 2
Study: 8588386

Group type: EXPERIMENTAL
Intervention: Nasal nocturnal oxygen therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 20
Study: 2006994

Group type: EXPERIMENTAL
Intervention: Felodipine, 10 mg once daily (extended release)
Number of subjects: 12
Study: 7006528

Group type: EXPERIMENTAL
Intervention: Truncal vagotomy and drainage (TV + D)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Selective gastric vagotomy and drainage (SV + D)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Parietal cell vagotomy without drainage (PCV)
Number of subjects: 259
Study: 31493287

Group type: EXPERIMENTAL
Intervention: Betrixaban 80 mg qd for 35-42 days
Number of subjects: 959

Group type: COMPARATOR
Intervention: Enoxaparin 40 mg qd for 10 ± 4 days
Number of subjects: 959
Study: 31476336

Group type: EXPERIMENTAL
Intervention: Skin cancer screening (ever life-time skin examination)
Number of subjects: 60764

Group type: EXPERIMENTAL
Intervention: Skin cancer screening (skin examination in the current year)
Number of subjects: 60764

Group type: EXPERIMENTAL
Intervention: Educational differences in ever life-time skin examination
Number of subjects: 60764
Study: 29665762

Group type: EXPERIMENTAL
Intervention: 240 mg vitamin B6 (pyridoxine hydrochloride) before bed for five consecutive days
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: B complex preparation containing a range of B vitamins
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 26755225

Group type: EXPERIMENTAL
Intervention: 10% sodium ascorbate (SA) gel, delayed bonding (1-week)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Immediate bonding after bleaching
Number of subjects: 140

Group type: COMPARATOR
Intervention: Adper Single Bond 2 total-etch and Clearfil Tri S Bond self-etch adhesives (control)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Bleaching with 35% Beyond Max and 38% Opalescence Xtra Boost
Number of subjects: 140
Study: 24141646

Group type: EXPERIMENTAL
Intervention: Diclofenac 75 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Parecoxib 40 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Paracetamol 1 g
Number of subjects: 36

Group type: COMPARATOR
Intervention: Isotonic saline
Number of subjects: 36
Study: 23279702

Group type: EXPERIMENTAL
Intervention: 1540-nm nonablative fractional laser therapy (NAFL), four treatments at monthly intervals
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control side (untreated)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 1540-nm nonablative fractional laser therapy (NAFL)
Number of subjects: 18
Study: 20837777

Group type: EXPERIMENTAL
Intervention: Affect misattribution procedure (AMP)
Number of subjects: 0
Study: 18827046

Group type: EXPERIMENTAL
Intervention: Stapler closure technique
Number of subjects: 336

Group type: COMPARATOR
Intervention: Hand-sewn closure technique
Number of subjects: 336
Study: 17177902

Group type: EXPERIMENTAL
Intervention: Bed exercises for 30 min every day for 6 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both groups (exercise and control)
Number of subjects: 35
Study: 12940928

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 22
Study: 10823761

Group type: EXPERIMENTAL
Intervention: Subcutaneous interleukin‐2 (IL‐2) at doses of 1.5 MIU, 4.5 MIU, and 7.5 MIU per dose, delivered by twice‐daily injection for 5 consecutive days every 8 weeks
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Subcutaneous interleukin‐2 (IL‐2) at 4.5 MIU
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Subcutaneous interleukin‐2 (IL‐2) at 7.5 MIU
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (ART alone)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Subcutaneous interleukin‐2 (IL‐2) at 1.5 MIU
Number of subjects: 73
Study: 8880038

Group type: EXPERIMENTAL
Intervention: Mono-diet (high-fat, monounsaturated-fat enriched)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Poly-diet (reduced-fat, polyunsaturated-fat enriched)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Mono-diet
Number of subjects: 31

Group type: COMPARATOR
Intervention: Poly-diet
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Mono-diet and Poly-diet
Number of subjects: 31
Study: 8315204

Group type: EXPERIMENTAL
Intervention: D3X4 lens
Number of subjects: 15

Group type: COMPARATOR
Intervention: Novalens (Ocu‐Tec)
Number of subjects: 15

Group type: COMPARATOR
Intervention: ENVISION (Polymer Technology Corporation)
Number of subjects: 15
Study: 3719618

Group type: EXPERIMENTAL
Intervention: CM
Number of subjects: 175

Group type: COMPARATOR
Intervention: PH
Number of subjects: 175

Group type: COMPARATOR
Intervention: IG
Number of subjects: 175
Study: 30086592

Group type: EXPERIMENTAL
Intervention: Prostatic Urethral Lift (PUL; Urolift)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temporary Implantable Nitinol Device (TIND)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rezũm (ablative technology)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aquablation (AquaBeam)
Number of subjects: 0
Study: 27270858

Group type: EXPERIMENTAL
Intervention: Pharmacological treatment (valproic acid, fluoxetine, risperidone, lorazepam) for 12 weeks
Number of subjects: 89
Study: 24886647

Group type: EXPERIMENTAL
Intervention: TEAS (IVF + TEAS)
Number of subjects: 2220

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA) (IVF + EA)
Number of subjects: 2220

Group type: COMPARATOR
Intervention: Control (only IVF)
Number of subjects: 2220
Study: 25409597

Group type: EXPERIMENTAL
Intervention: Transportal technique
Number of subjects: 80

Group type: COMPARATOR
Intervention: Transtibial technique
Number of subjects: 80
Study: 22578793

Group type: EXPERIMENTAL
Intervention: Temozolomide (100 mg/m², days 1-7 of 1 week on, 1 week off cycles)
Number of subjects: 412

Group type: COMPARATOR
Intervention: Radiotherapy (60.0 Gy over 6-7 weeks in 30 fractions of 1.8-2.0 Gy)
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Temozolomide (with MGMT promoter methylation)
Number of subjects: 412

Group type: COMPARATOR
Intervention: Radiotherapy (with MGMT promoter methylation)
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Temozolomide (without MGMT promoter methylation)
Number of subjects: 412

Group type: COMPARATOR
Intervention: Radiotherapy (without MGMT promoter methylation)
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Temozolomide
Number of subjects: 412

Group type: COMPARATOR
Intervention: Radiotherapy
Number of subjects: 412
Study: 20618554

Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03% gel
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study: 17554104

Group type: EXPERIMENTAL
Intervention: Single-row suture anchor technique
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Double-row suture anchor technique
Number of subjects: 60
Study: 15774531

Group type: EXPERIMENTAL
Intervention: Insulin-mediated glucose clearance in arm (1 pmol min-1 kg-1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Insulin-mediated glucose clearance in leg (1 pmol min-1 kg-1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Basal glucose clearance in arm
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Basal glucose clearance in leg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Blood flow in arm
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Blood flow in leg
Number of subjects: 12
Study: 11938697

Group type: EXPERIMENTAL
Intervention: Single dose (600 mg) of albendazole with fatty food
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mebendazole (100 mg, twice a day, fasting state)
Number of subjects: 0
Study: 10541425

Group type: EXPERIMENTAL
Intervention: TAA-HFA 450, 900, or 1800 microg/day
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: TAA-CFC 450 or 900 microg/day
Number of subjects: 538

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 538
Study: 8708885

Group type: EXPERIMENTAL
Intervention: Intravenous lipid (IVL) administration on day 5
Number of subjects: 64

Group type: COMPARATOR
Intervention: Intravenous lipid (IVL) administration on day 14
Number of subjects: 64
Study: 1824799

Group type: EXPERIMENTAL
Intervention: 300 mg/day of sodium clodronate given intravenously as a 3‐hour infusion for 20 days
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 300 mg/day of sodium clodronate given intravenously as a 3‐hour infusion for 10 days
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 300 mg/day of sodium clodronate given intravenously as a 3‐hour infusion for both groups
Number of subjects: 28
Study: 6653647

Group type: EXPERIMENTAL
Intervention: Verapamil 80 mg t.i.d.
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Combined verapamil (80 mg t.i.d.) and quinidine (160 mg t.i.d.)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 30613911

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 0
Study: 29274893

Group type: EXPERIMENTAL
Intervention: Acceptance-based treatment (ABT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard behavioral treatment (SBT)
Number of subjects: 0
Study: 26829478

Group type: EXPERIMENTAL
Intervention: Standardized pre-operative telephone checklist administered between 7 and 3 days before surgery.
Number of subjects: 3900

Group type: COMPARATOR
Intervention: Standard management alone (control group).
Number of subjects: 3900
Study: 25146896

Group type: EXPERIMENTAL
Intervention: Fomentation combined with Chinese herbal
Number of subjects: 76

Group type: COMPARATOR
Intervention: Fomentation without any medicine (Control Group)
Number of subjects: 76
Study: 22486344

Group type: EXPERIMENTAL
Intervention: Menthol cigarette
Number of subjects: 9

Group type: COMPARATOR
Intervention: Nonmenthol cigarette
Number of subjects: 9